Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fruehauf

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Cancer Gene Therapy|May 16, 2000
Differential expression of a recombinant adeno-associated virus 2 vector in human CD34+ cells and breast cancer cellsM R Veldwijk, S Fruehauf, B Schiedlmeier, et al.
Acta Haematologica|August 7, 1999
Comparison of different lymphoma cell purging modalities: An experimental study with K422 lymphoma cellsP Hundsdörfer, S Fruehauf, M Haberkorn, et al.
Human Gene Therapy|July 8, 1999
Soluble bone marrow stroma factors improve the efficiency of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cellsB Schiedlmeier, E C Buss, M R Veldwijk, et al.
Neurology|May 25, 2005
Presynaptic dopaminergic pathology in Chediak-Higashi syndrome with parkinsonian syndromeC Jacobi, C Koerner, S Fruehauf, et al.
Cancer Chemotherapy and Pharmacology|September 29, 1999
Favorable therapeutic index of a p210(BCR-ABL)-specific tyrosine kinase inhibitor; activity on lineage-committed and primitive chronic myelogenous leukemia progenitorsB Kasper, S Fruehauf, B Schiedlmeier, et al.
Blood|April 1, 1995
Blood-derived autografts collected during granulocyte colony-stimulating factor-enhanced recovery are enriched with early Thy-1+ hematopoietic progenitor cellsR Haas, R Möhle, M Pförsich, et al.
Blood|May 1, 1995
Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapyS Fruehauf, R Haas, C Conradt, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 1999
Adhesion to fibronectin stimulates proliferation of wild-type and bcr/abl-transfected murine hematopoietic cellsA Krämer, S Hörner, A Willer, et al.
Blood|February 9, 2000
Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient miceB Schiedlmeier, K Kühlcke, H G Eckert, et al.
Journal of Virology|December 14, 2007
Multiple displacement amplification enables large-scale clonal analysis following retroviral gene therapyS Bleier, P Maier, H Allgayer, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Cancer Gene Therapy|May 16, 2000
Differential expression of a recombinant adeno-associated virus 2 vector in human CD34+ cells and breast cancer cellsM R Veldwijk, S Fruehauf, B Schiedlmeier, et al.
Acta Haematologica|August 7, 1999
Comparison of different lymphoma cell purging modalities: An experimental study with K422 lymphoma cellsP Hundsdörfer, S Fruehauf, M Haberkorn, et al.
Human Gene Therapy|July 8, 1999
Soluble bone marrow stroma factors improve the efficiency of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cellsB Schiedlmeier, E C Buss, M R Veldwijk, et al.
Neurology|May 25, 2005
Presynaptic dopaminergic pathology in Chediak-Higashi syndrome with parkinsonian syndromeC Jacobi, C Koerner, S Fruehauf, et al.
Cancer Chemotherapy and Pharmacology|September 29, 1999
Favorable therapeutic index of a p210(BCR-ABL)-specific tyrosine kinase inhibitor; activity on lineage-committed and primitive chronic myelogenous leukemia progenitorsB Kasper, S Fruehauf, B Schiedlmeier, et al.
Blood|April 1, 1995
Blood-derived autografts collected during granulocyte colony-stimulating factor-enhanced recovery are enriched with early Thy-1+ hematopoietic progenitor cellsR Haas, R Möhle, M Pförsich, et al.
Blood|May 1, 1995
Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapyS Fruehauf, R Haas, C Conradt, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 1999
Adhesion to fibronectin stimulates proliferation of wild-type and bcr/abl-transfected murine hematopoietic cellsA Krämer, S Hörner, A Willer, et al.
Blood|February 9, 2000
Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient miceB Schiedlmeier, K Kühlcke, H G Eckert, et al.
Journal of Virology|December 14, 2007
Multiple displacement amplification enables large-scale clonal analysis following retroviral gene therapyS Bleier, P Maier, H Allgayer, et al.
Pageof 6